HRP20090447T1 - Farmaceutski pripravci koji sadrže diaminooksidazu - Google Patents
Farmaceutski pripravci koji sadrže diaminooksidazu Download PDFInfo
- Publication number
- HRP20090447T1 HRP20090447T1 HR20090447T HRP20090447T HRP20090447T1 HR P20090447 T1 HRP20090447 T1 HR P20090447T1 HR 20090447 T HR20090447 T HR 20090447T HR P20090447 T HRP20090447 T HR P20090447T HR P20090447 T1 HRP20090447 T1 HR P20090447T1
- Authority
- HR
- Croatia
- Prior art keywords
- drug
- preparation
- diamine oxidase
- gastric acid
- oral
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims abstract 8
- 229960001340 histamine Drugs 0.000 claims abstract 4
- 102000016893 Amine Oxidase (Copper-Containing) Human genes 0.000 claims 11
- 108010028700 Amine Oxidase (Copper-Containing) Proteins 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 11
- 229940079593 drug Drugs 0.000 claims 11
- 210000004211 gastric acid Anatomy 0.000 claims 7
- 239000002552 dosage form Substances 0.000 claims 6
- 208000024780 Urticaria Diseases 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 239000006187 pill Substances 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010052568 Urticaria chronic Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000024376 chronic urticaria Diseases 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 230000000378 dietary effect Effects 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 102000004316 Oxidoreductases Human genes 0.000 abstract 1
- 108090000854 Oxidoreductases Proteins 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
- C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
- C12Y104/03006—Amine oxidase (copper-containing)(1.4.3.6)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Farmaceutski pripravak za liječenje oboljenja induciranih histaminom, koji sadrži diaminooksidazu, naznačen time, da je pripravak pripremljen u dozirnom obliku zaštićenom od želučane kiseline za oralnu ili peroralnu primjenu. Patent sadrži još 13 patentnih zahtjeva.
Claims (14)
1. Farmaceutski pripravak za liječenje oboljenja induciranih histaminom, koji sadrži diaminooksidazu, naznačen time, da je pripravak pripremljen u dozirnom obliku zaštićenom od želučane kiseline za oralnu ili peroralnu primjenu.
2. Pripravak u skladu sa zahtjevom 1, naznačen time, da je pripremljen u obliku pilule ili kapsule rezistentne na želučanu kiselinu.
3. Pripravak u skladu sa zahtjevom 1 ili 2, naznačen time, da diaminooksidaza nije biljnog podrijetla.
4. Pripravak u skladu sa zahtjevom 3, naznačen time, da sadrži diaminooksidazu životinjskog podrijetla.
5. Pripravak u skladu sa zahtjevom 4, naznačen time, da je diaminooksidaza dobivena iz svinjskih bubrega.
6. Pripravak u skladu sa bilo kojim zahtjevom 1 do 4, naznačen time, da sadrži diaminooksidazu rekombinantnog podrijetla.
7. Pripravak u skladu sa zahtjevom 6, naznačen time, da sadrži rekombinantnu diaminooksidazu dobivenu iz prokariotskih, povoljno je bakterijskih, ili iz eukariotskih, povoljno je životinjskih ili gljivičnih, staničnih kultura.
8. Uporaba farmaceutskog pripravka u skladu sa bilo kojim zahtjevom 1 do 7, naznačena time, da se koristi kao dodatak hrani ili kao dijetalna hrana.
9. Uporaba diaminooksidaze za pripravu lijeka za liječenje histaminom induciranih kliničkih slika, naznačena time, da je lijek u dozirnom obliku zaštićenom od želučane kiseline za oralnu ili peroralnu primjenu.
10. Uporaba diaminooksidaze za pripravu lijeka za liječenje urtikarije, posebno kronične i akutne urtikarije, naznačena time, da je lijek u dozirnom obliku zaštićenom od želučane kiseline za oralnu ili peroralnu primjenu.
11. Uporaba diaminooksidaze za pripravu lijeka za liječenje atopičkog dermatitisa, naznačena time, da je lijek u dozirnom obliku zaštićenom od želučane kiseline za oralnu ili peroralnu primjenu.
12. Uporaba diaminooksidaze za pripravu lijeka za liječenje skombrotoksizma, naznačena time, da je lijek u dozirnom obliku zaštićenom od želučane kiseline za oralnu ili peroralnu primjenu.
13. Uporaba diaminooksidaze za pripravu lijeka za uklanjanje histamina iz želučano-crijevnog trakta, naznačena time, da je lijek u dozirnom obliku zaštićenom od želučane za oralnu ili peroralnu primjenu.
14. Uporaba u skladu sa bilo kojim zahtjevom 9 do 13, naznačena time, da je lijek u obliku pilule ili kapsule rezistentne na želučanu kiselinu.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0115004A AT502098B8 (de) | 2004-07-07 | 2004-07-07 | Diaminooxidase-hältige zusammensetzung |
PCT/EP2005/053234 WO2006003213A1 (de) | 2004-07-07 | 2005-07-06 | Pharmazeutische zusammensetzungen, die diaminooxidase enthalten |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20090447T1 true HRP20090447T1 (hr) | 2009-11-30 |
Family
ID=34971770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20090447T HRP20090447T1 (hr) | 2004-07-07 | 2009-08-20 | Farmaceutski pripravci koji sadrže diaminooksidazu |
Country Status (20)
Country | Link |
---|---|
US (3) | US20080193491A1 (hr) |
EP (2) | EP1763363B1 (hr) |
JP (1) | JP4959558B2 (hr) |
KR (1) | KR101367232B1 (hr) |
CN (1) | CN1980689A (hr) |
AT (4) | AT502098B8 (hr) |
AU (1) | AU2005259167B2 (hr) |
BR (1) | BRPI0513133B1 (hr) |
CA (1) | CA2571463C (hr) |
CY (1) | CY1109351T1 (hr) |
DE (2) | DE502005009568D1 (hr) |
DK (1) | DK1763363T3 (hr) |
ES (1) | ES2326421T3 (hr) |
HR (1) | HRP20090447T1 (hr) |
MX (1) | MXPA06015036A (hr) |
PL (1) | PL1763363T3 (hr) |
PT (1) | PT1763363E (hr) |
RS (1) | RS51183B (hr) |
SI (1) | SI1763363T1 (hr) |
WO (1) | WO2006003213A1 (hr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2388395B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención de la fibromialgia o la fatiga crónica. |
ES2387973B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Composiciones tópicas que contienen diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que comportan un aumento del dolor. |
US20160024481A1 (en) * | 2011-03-18 | 2016-01-28 | Dr Healthcare España, S.L. | Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |
US20170020993A1 (en) * | 2011-03-18 | 2017-01-26 | Dr Healthcare España, S.L. | Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |
ES2388515B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para la prevención de los síntomas de la resaca. |
ES2388166B1 (es) * | 2011-03-18 | 2013-10-01 | Dr Healthcare España, S. L. | Alimentos funcionales que contienen diaminooxidasa y sus usos. |
EP2694098B1 (en) * | 2011-04-07 | 2018-09-26 | Histapharm Inc. | Oral enzyme compositions for intestinal delivery |
ES2426539B1 (es) | 2012-04-18 | 2014-09-09 | Dr Healthcare España, S. L. | Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd) |
AU2018388566A1 (en) * | 2017-12-21 | 2020-06-18 | Pepsico, Inc. | Multi-ingredient ephemeral beverage pod for making a beverage |
CN113785052A (zh) | 2019-02-19 | 2021-12-10 | 维也纳兽医大学 | 新重组二胺氧化酶及其治疗以过量组胺为特征的疾病的用途 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB479487A (en) * | 1935-08-01 | 1938-02-04 | Ig Farbenindustrie Ag | Manufacture of stable therapeutic products from intestinal mucous membrane |
NL6815177A (hr) * | 1968-10-24 | 1970-04-28 | ||
GB1318884A (en) * | 1969-07-29 | 1973-05-31 | Hydrovane Compressor | Rotary compressors |
FR2101095A1 (en) * | 1970-08-20 | 1972-03-31 | Merieux Inst | Diamine oxidase from human placenta - for treatment of hyperhistamina |
US3639579A (en) * | 1970-12-10 | 1972-02-01 | Matthew C Urbin | Pharmaceutical preparation |
FR2215944A1 (en) * | 1973-02-01 | 1974-08-30 | Bellon Labor Sa Roger | Extracts of human placenta - free of proteases, and contg. histaminase, kininases and monoamine-oxidases for treating allergies |
FR2529463B1 (fr) * | 1982-07-05 | 1986-01-10 | Centre Nat Rech Scient | Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus |
GB8319540D0 (en) * | 1983-07-20 | 1983-08-24 | Bovril Ltd | Amine removal |
US4725540A (en) * | 1984-07-09 | 1988-02-16 | Emil Underberg | Process for the preparation of amine-oxidase containing material, so produced amine-oxidase containing material |
US5270033A (en) * | 1991-11-25 | 1993-12-14 | Montgomery Robert E | Antimicrobial composition and method of making same |
ES2233106T3 (es) * | 1998-11-27 | 2005-06-01 | Kanji Takada | Preparacion oral para administracion gastrointestinal de un medicamento. |
JP4839506B2 (ja) | 2000-04-28 | 2011-12-21 | ダイキン工業株式会社 | ドライエッチング方法 |
JP4592041B2 (ja) * | 2000-11-24 | 2010-12-01 | 株式会社Nrlファーマ | 生活の質を改善する新規食品の製造法および用途 |
IT1317067B1 (it) * | 2000-11-29 | 2003-05-26 | Univ Roma | Istaminasi di origine vegetale nel trattamento dello shock allergico esettico e nell'asma allergico. |
CA2433408A1 (en) * | 2001-02-23 | 2002-08-29 | Biovitrum Ab | Method for purification of soluble ssao |
JP2003212773A (ja) * | 2002-01-04 | 2003-07-30 | Oramon Arzneimittel Gmbh | セチリジン及びロラタジンの局所医薬組成物 |
DE10239029A1 (de) | 2002-08-21 | 2004-03-04 | Coty B.V. | Kosmetische und dermatologische Zubereitung mit Proteinen zur Hautaufhellung |
JP2004167178A (ja) * | 2002-11-15 | 2004-06-17 | Masashi Takahashi | タン白質の経口投与法 |
-
2004
- 2004-07-07 AT AT0115004A patent/AT502098B8/de not_active IP Right Cessation
-
2005
- 2005-07-06 ES ES05758617T patent/ES2326421T3/es active Active
- 2005-07-06 DE DE502005009568T patent/DE502005009568D1/de active Active
- 2005-07-06 PL PL05758617T patent/PL1763363T3/pl unknown
- 2005-07-06 CA CA2571463A patent/CA2571463C/en active Active
- 2005-07-06 WO PCT/EP2005/053234 patent/WO2006003213A1/de active Application Filing
- 2005-07-06 EP EP05758617A patent/EP1763363B1/de active Active
- 2005-07-06 PT PT05758617T patent/PT1763363E/pt unknown
- 2005-07-06 CN CNA2005800227917A patent/CN1980689A/zh active Pending
- 2005-07-06 AU AU2005259167A patent/AU2005259167B2/en not_active Ceased
- 2005-07-06 SI SI200530749T patent/SI1763363T1/sl unknown
- 2005-07-06 AT AT07101239T patent/ATE467423T1/de active
- 2005-07-06 MX MXPA06015036A patent/MXPA06015036A/es active IP Right Grant
- 2005-07-06 DE DE502005007425T patent/DE502005007425D1/de active Active
- 2005-07-06 AT AT05758617T patent/ATE432710T1/de active
- 2005-07-06 KR KR1020077002826A patent/KR101367232B1/ko not_active IP Right Cessation
- 2005-07-06 JP JP2007519799A patent/JP4959558B2/ja not_active Expired - Fee Related
- 2005-07-06 BR BRPI0513133A patent/BRPI0513133B1/pt not_active IP Right Cessation
- 2005-07-06 DK DK05758617T patent/DK1763363T3/da active
- 2005-07-06 EP EP07101239A patent/EP1782824B1/de active Active
- 2005-07-06 RS RSP-2009/0371A patent/RS51183B/sr unknown
- 2005-07-06 US US11/571,732 patent/US20080193491A1/en not_active Abandoned
-
2006
- 2006-09-29 AT AT0162706A patent/AT503070B1/de active
-
2009
- 2009-08-20 HR HR20090447T patent/HRP20090447T1/hr unknown
- 2009-08-28 CY CY20091100902T patent/CY1109351T1/el unknown
-
2010
- 2010-08-24 US US12/862,379 patent/US8716244B2/en active Active
-
2014
- 2014-04-04 US US14/245,358 patent/US9364437B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20090447T1 (hr) | Farmaceutski pripravci koji sadrže diaminooksidazu | |
TWI574633B (zh) | 包含益生菌及益生質成分及礦物鹽及乳鐵蛋白之組合物 | |
US9050323B2 (en) | Methods of treating destructive inflammation of the mucous membranes with lactoferrin | |
CN109310653A (zh) | 用于控制释放半胱胺和系统治疗半胱胺敏感性病症的组合物 | |
HRP20160507T1 (hr) | Novi farmaceutski pripravak za preeklampsiju | |
JP2007526248A5 (hr) | ||
ES2390226T3 (es) | Tratamiento de enfermedades infecciosas | |
WO2006123248A3 (en) | Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject | |
EA201590835A1 (ru) | Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием | |
ES2932498T3 (es) | Composiciones que comprenden el péptido WKDEAGKPLVK | |
RU2008122368A (ru) | Композиция штаммов рода lactobacillus и применение композиции штаммов рода lactobacillus | |
BRPI0418681A (pt) | um suplemento dietético para o tratamento e a prevenção de doenças do sistema digestivo e doenças relacionadas ao sistema digestivo e método de produção e administração deste | |
RU2011124506A (ru) | Фармацевтический препарат, содержащий комбинацию штаммов streptococcus и штаммов lactobacillus | |
CN101559198B (zh) | 一种保护关节、软组织的药物 | |
CN102178167A (zh) | 茯苓营养挂面及制备方法 | |
WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
JP2017526695A5 (hr) | ||
EP2597972A1 (en) | Use of a mixture of probiotic bacteria in a mixture with short - chain fatty acids | |
RCK Rajendran et al. | Preclinical evidence on the anticancer properties of food peptides | |
RU2468812C2 (ru) | Средство, обладающее адаптогенным, тонизирующим и общеукрепляющим действием, и способ его получения | |
Ji et al. | Dietary intervention to reduce E. coli infectious diarrhea in young pigs | |
WO2009019307A3 (en) | Oral calcitonin compositions and applications thereof | |
KR20220080120A (ko) | 위장 건강 조성물 | |
TWI576117B (zh) | 玻尿酸產生促進劑 | |
EP2701691B1 (en) | Composition for prevention and treatment of rheumatoid arthritis |